FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4300716401> ?p ?o ?g. }

• W4300716401 abstract "Objective Achieving functional recovery after cesarean delivery is critical to a parturient’s ability to care for herself and her newborn. Adequate pain control is vital, and without it, many other aspects of the recovery process may be delayed. Reducing opioid consumption without compromising analgesia is of paramount importance, and enhanced recovery pathways have generated considerable interest given their ability to facilitate this. Our group’s process for reducing opioid consumption for cesarean delivery patients evolved over time. We first demonstrated that providing additional incisional pain control with continuous bupivacaine infusions through wound catheters, with the concurrent use of neuraxial morphine, reduced postoperative opioid use. Iterations of an enhanced recovery after cesarean (ERAC) delivery pathway were then implemented after the Society for Obstetric Anesthesia and Perinatology’s consensus statement for ERAC was issued to eliminate variability in both hospital course and in the treatment of postoperative pain. In this retrospective cohort analysis, we sought to identify whether adding ERAC protocols to our existing combination of neuraxial morphine and wound soaker catheters further reduced opioid consumption after cesarean delivery.Methods A retrospective cohort analysis of cesarean deliveries from 2015 through 2020 was performed. Deliveries were divided by analgesic pathway into four time-periods – time-point 1 [January 2015-April 2016, previous standard of care (control, N = 61)]: neuraxial morphine in addition to as needed opioid and non-opioid analgesics; time-point 2 [May 2016–May 2019, introduction of wound soaker (wound-soaker, N = 40)]: continuous wound catheter infusions of local anesthetic, neuraxial morphine in addition to as needed opioid and non-opioid analgesics; time-point 3 [May 2019–December 2019, wound soaker + early ERAC pathway (early ERAC, N = 78)]: continuous wound catheter infusion of local anesthetic, neuraxial morphine, in addition to scheduled non-opioid analgesics (acetaminophen and ibuprofen) every 6 h, alternating in relation to one another so that one is given every 3 h; time-point 4 [January 2020–July 2020, wound soaker + late ERAC pathway (late ERAC, N = 57)]: continuous wound catheter infusion of local anesthetic, neuraxial morphine in addition to non-opioid analgesics scheduled together every 6 h (to facilitate periods of uninterrupted rest). Cumulative and average daily opioid use for postoperative days (POD) 1–4 were analyzed using ANOVA and a mixed effect model, respectively.Results Average daily opioid consumption and total cumulative opioid consumption POD 1–4 (morphine milligram equivalents) for both early and late ERAC groups (23.9 ± 31.1 and 29.4 ± 35.1) were significantly reduced compared to control and wound soaker groups (185.1 ± 93.7 and 134.8 ± 77.1) (p < .001).Conclusion The addition of ERAC protocols to our standardized multimodal analgesic regimen (local anesthetic wound infusion catheters and neuraxial morphine) for cesarean delivery significantly reduced postoperative opioid consumption." @default.
• W4300716401 created "2022-10-04" @default.
• W4300716401 creator A5002310289 @default.
• W4300716401 creator A5028407166 @default.
• W4300716401 creator A5041054723 @default.
• W4300716401 creator A5042763505 @default.
• W4300716401 creator A5047698542 @default.
• W4300716401 creator A5076194602 @default.
• W4300716401 date "2022-10-03" @default.
• W4300716401 modified "2023-09-30" @default.
• W4300716401 title "Evolution of postoperative care: marked reduction of opioid consumption when ERAC pathway added to wound soaker therapy for cesarean delivery" @default.
• W4300716401 cites W1978953300 @default.
• W4300716401 cites W1985990188 @default.
• W4300716401 cites W1990251399 @default.
• W4300716401 cites W2005029938 @default.
• W4300716401 cites W2042716089 @default.
• W4300716401 cites W2066382523 @default.
• W4300716401 cites W2069523442 @default.
• W4300716401 cites W2102263549 @default.
• W4300716401 cites W2300492567 @default.
• W4300716401 cites W2318718165 @default.
• W4300716401 cites W2336245881 @default.
• W4300716401 cites W2536228031 @default.
• W4300716401 cites W2550878516 @default.
• W4300716401 cites W2806178297 @default.
• W4300716401 cites W2969350152 @default.
• W4300716401 cites W3002984828 @default.
• W4300716401 cites W3028711125 @default.
• W4300716401 cites W3031194314 @default.
• W4300716401 cites W3085766097 @default.
• W4300716401 cites W3104737655 @default.
• W4300716401 cites W3112505860 @default.
• W4300716401 cites W4226144443 @default.
• W4300716401 doi "https://doi.org/10.1080/14767058.2022.2130241" @default.
• W4300716401 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36191923" @default.
• W4300716401 hasPublicationYear "2022" @default.
• W4300716401 type Work @default.
• W4300716401 citedByCount "0" @default.
• W4300716401 crossrefType "journal-article" @default.
• W4300716401 hasAuthorship W4300716401A5002310289 @default.
• W4300716401 hasAuthorship W4300716401A5028407166 @default.
• W4300716401 hasAuthorship W4300716401A5041054723 @default.
• W4300716401 hasAuthorship W4300716401A5042763505 @default.
• W4300716401 hasAuthorship W4300716401A5047698542 @default.
• W4300716401 hasAuthorship W4300716401A5076194602 @default.
• W4300716401 hasBestOaLocation W43007164011 @default.
• W4300716401 hasConcept C126322002 @default.
• W4300716401 hasConcept C141071460 @default.
• W4300716401 hasConcept C167135981 @default.
• W4300716401 hasConcept C170493617 @default.
• W4300716401 hasConcept C2777389121 @default.
• W4300716401 hasConcept C2779234561 @default.
• W4300716401 hasConcept C2781063702 @default.
• W4300716401 hasConcept C2991742891 @default.
• W4300716401 hasConcept C3020128735 @default.
• W4300716401 hasConcept C42219234 @default.
• W4300716401 hasConcept C54355233 @default.
• W4300716401 hasConcept C71924100 @default.
• W4300716401 hasConcept C86803240 @default.
• W4300716401 hasConceptScore W4300716401C126322002 @default.
• W4300716401 hasConceptScore W4300716401C141071460 @default.
• W4300716401 hasConceptScore W4300716401C167135981 @default.
• W4300716401 hasConceptScore W4300716401C170493617 @default.
• W4300716401 hasConceptScore W4300716401C2777389121 @default.
• W4300716401 hasConceptScore W4300716401C2779234561 @default.
• W4300716401 hasConceptScore W4300716401C2781063702 @default.
• W4300716401 hasConceptScore W4300716401C2991742891 @default.
• W4300716401 hasConceptScore W4300716401C3020128735 @default.
• W4300716401 hasConceptScore W4300716401C42219234 @default.
• W4300716401 hasConceptScore W4300716401C54355233 @default.
• W4300716401 hasConceptScore W4300716401C71924100 @default.
• W4300716401 hasConceptScore W4300716401C86803240 @default.
• W4300716401 hasIssue "1" @default.
• W4300716401 hasLocation W43007164011 @default.
• W4300716401 hasLocation W43007164012 @default.
• W4300716401 hasOpenAccess W4300716401 @default.
• W4300716401 hasPrimaryLocation W43007164011 @default.
• W4300716401 hasRelatedWork W1975265436 @default.
• W4300716401 hasRelatedWork W2024571461 @default.
• W4300716401 hasRelatedWork W2123259325 @default.
• W4300716401 hasRelatedWork W2746909351 @default.
• W4300716401 hasRelatedWork W2971374060 @default.
• W4300716401 hasRelatedWork W2998554988 @default.
• W4300716401 hasRelatedWork W3012318696 @default.
• W4300716401 hasRelatedWork W4213303600 @default.
• W4300716401 hasRelatedWork W4324018664 @default.
• W4300716401 hasRelatedWork W4386758314 @default.
• W4300716401 hasVolume "36" @default.
• W4300716401 isParatext "false" @default.
• W4300716401 isRetracted "false" @default.
• W4300716401 workType "article" @default.